Clinical Trial-Clinical Trial Center, Kaohsiung Medical University Chung-Ho Memorial Hospital

Trial Section

  Home / Trial Section / Clinical Trial
Indication Department Study Title Study Phase Investigator Contact Person Status
心衰竭 Cardiology HERMES: Effects of ziltivekimab versus placebo on morbidity and mortality in patients with heart failure with mildly reduced or preserved ejection fraction and systemic inflammation. Phase III Tsung-Hsien Lin 馬瑞珍 On-going
Hepatitis Hepatobiliary and Pancreatic Medicine An Open-label Study Evaluating the Safety, Antiviral Activity, and Pharmacokinetics of IMC-I109V in HLA-A*02:01 Positive Patients with Chronic HBV Infection who are Non-Cirrhotic, Hepatitis B e Antigen-negative, and virally suppressed Phase I Wan-Long Chuang 劉宜樺 On-going
Hypertension Cardiology A Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy and Safety of Baxdrostat in Participants with Uncontrolled Hypertension on Two or More Medications including Participants with Resistant Hypertension Phase III Tsung-Hsien Lin 林皓雯 On-going
Prostate Cancer Urology A Randomized, 2-cohort, Double-blind, Placebo-controlled, Phase III Study of AZD5305 in Combination with Physician’s Choice New Hormonal Agents in Patients with HRRm and non-HRRm Metastatic Castration-Sensitive Prostate Cancer (EvoPAR-Prostate01) Phase III Wen-Jeng Wu 林詩涵 On-going
Rehabilitation Medicine The effects of Swallowing Exercise in stroke patients with dysphagia -- KO YI CHUN On-going
Rehabilitation Medicine Developing a Mobile Brain-Controlled Bipedal Exoskeleton for Enhancing Post-Stroke Rehabilitation -- Chen Chia-Hsin On-going
Rehabilitation Medicine Clinical effect of pulmonary rehabilitation combined laser therapy in chest wall muscle group in patients with chronic obstructive pulmonary disease -- Chen Chia-Hsin 周智亮 On-going
Gout Rheumatology, Immunology and Allergology A multi-center, randomized, double-blind, active-controlled, therapeutic confirmatory, phase III study to compare and evaluate the efficacy and safety of Epaminurad with Febuxostat in gout patients -- Cheng-Chin Wu On-going
Liver Cancer Hepatobiliary and Pancreatic Medicine A Phase 2, Randomized Study to Evaluate the Optimized Dose, Safety, and Efficacy of Livmoniplimab in Combination with Budigalimab for Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) Patients who Have Progressed After an Immune Checkpoint Inhibitor Containing Regimen in First-Line HCC Phase II Ming- Lung Yu 莊惠月 On-going
Solid Tumor Gastroenterology A Phase II, Open-label, Multi-centre Study to Evaluate Safety, Tolerability, Efficacy, PK, and Immunogenicity of AZD0901 as Monotherapy and in Combination with Anti-cancer Agents in Participants with Advanced Solid Tumours Expressing Claudin 18.2. Phase II I-Chen Wu 崔雅潔 On-going

 ←   Please slide to the left for more information